These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hapten optimization for cocaine vaccine with improved cocaine recognition. Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171 [TBL] [Abstract][Full Text] [Related]
5. Antibody-catalyzed degradation of cocaine. Landry DW; Zhao K; Yang GX; Glickman M; Georgiadis TM Science; 1993 Mar; 259(5103):1899-901. PubMed ID: 8456315 [TBL] [Abstract][Full Text] [Related]
6. Cocaine catalytic antibodies: the primary importance of linker effects. Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477 [TBL] [Abstract][Full Text] [Related]
7. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten. Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032 [TBL] [Abstract][Full Text] [Related]
8. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog. Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011 [TBL] [Abstract][Full Text] [Related]
9. Complete reaction cycle of a cocaine catalytic antibody at atomic resolution. Zhu X; Dickerson TJ; Rogers CJ; Kaufmann GF; Mee JM; McKenzie KM; Janda KD; Wilson IA Structure; 2006 Feb; 14(2):205-16. PubMed ID: 16472740 [TBL] [Abstract][Full Text] [Related]
10. Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Stewart DJ; Inaba T; Lucassen M; Kalow W Clin Pharmacol Ther; 1979 Apr; 25(4):464-8. PubMed ID: 428191 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of single chain anti-cocaine catalytic antibodies. McKenzie KM; Mee JM; Rogers CJ; Hixon MS; Kaufmann GF; Janda KD J Mol Biol; 2007 Jan; 365(3):722-31. PubMed ID: 17084858 [TBL] [Abstract][Full Text] [Related]
12. Application of artificial enzymes to the problem of cocaine. De Prada P; Winger G; Landry DW Ann N Y Acad Sci; 2000; 909():159-69. PubMed ID: 10911929 [TBL] [Abstract][Full Text] [Related]
14. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10. Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502 [TBL] [Abstract][Full Text] [Related]
15. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination. Wenthur CJ; Cai X; Ellis BA; Janda KD Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828 [TBL] [Abstract][Full Text] [Related]
16. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis. Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500 [TBL] [Abstract][Full Text] [Related]
17. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1. Winsnes R; Sesardic D; Daas A; Behr-Gross ME Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262 [TBL] [Abstract][Full Text] [Related]